|
Volumn 30, Issue 4, 2012, Pages 297-299
|
Biotech innovators jump on biosimilars bandwagon
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOSIMILAR AGENT;
INSULIN;
BIOPROCESS;
BIOTECHNOLOGY;
DRUG COST;
DRUG INDUSTRY;
MARKET;
NOTE;
PATENT;
PRIORITY JOURNAL;
BIOSIMILAR PHARMACEUTICALS;
DRUG INDUSTRY;
EUROPE;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84859648674
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0412-297a Document Type: Note |
Times cited : (6)
|
References (0)
|